Triferic AVNU® (ferric pyrophosphate citrate) – New formulation approval
March 27, 2020 - Rockwell Medical announced the FDA approval of Triferic AVNU (ferric pyrophosphate citrate), an iron replacement product, for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).
Top